Metastatic melanoma disease activity may be monitored via circulating tumor DNA (ctDNA), which has higher sensitivity than lactate dehydrogenase (LDH) for detecting disease progression. These findings were reported in Molecular Oncology (doi:10.1016/j.molonc.2015.09.005).
MRV Research
Inherited Genetic Marker Discovered That May Predict Melanoma Disease Course and Survival
Melanoma is the most dangerous and lethal form of skin cancer. But just how long will a patient survive following the removal of a melanoma tumour?
Melanoma risk significant among pregnant women
The rising melanoma risk among women of child-bearing age is greatest in women younger than 50 who are pregnant or were recently pregnant, Cleveland Clinic researchers report in a new study.
Philogen Announces Commencement of Phase III Pivotal Trial in Melanoma
Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.